Bayesian Capital Management’s Conduent CNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-22,800
Closed -$109K 556
2020
Q4
$109K Buy
+22,800
New +$95.2K 0.03% 414
2020
Q2
Sell
-43,200
Closed -$106K 557
2020
Q1
$106K Buy
+43,200
New +$171K 0.02% 668
2018
Q4
Sell
-16,100
Closed -$363K 631
2018
Q3
$363K Sell
16,100
-18,900
-54% -$388K 0.06% 404
2018
Q2
$636K Sell
35,000
-16,100
-32% -$311K 0.14% 209
2018
Q1
$953K Buy
+51,100
New +$899K 0.24% 128
2017
Q4
Sell
-34,900
Closed -$547K 574
2017
Q3
$547K Buy
+34,900
New +$570K 0.13% 253

Other funds holding CNDT

Bayesian Capital Management's CNDT Position: Q1 2021 in Review

Bayesian Capital Management sold out of Conduent (CNDT) in Q1 2021, closing a stake of 22,800 shares — an estimated $109K sold.

Bayesian Capital Management first reported a position in CNDT in Q3 2017 and held it in 6 quarters. The position peaked at $953K in Q1 2018. 230 funds tracked by Wall St. Rank hold CNDT as of Q1 2021.

  • Bayesian Capital Management reported no remaining Conduent position as of Q1 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 22,800 Conduent shares in Q1 2021, an estimated $109K.
  • Bayesian Capital Management first reported a position in Conduent in Q3 2017 and held it in 6 quarters.
  • Bayesian Capital Management's Conduent position peaked at $953K in Q1 2018.
  • 230 funds tracked by Wall St. Rank held Conduent as of Q1 2021.

Based on Bayesian Capital Management's 13F filing for Q1 2021, filed 14 May 2021.